vs
ABVC BIOPHARMA, INC.（ABVC）与CXApp Inc.（CXAI）财务数据对比。点击上方公司名可切换其他公司
CXApp Inc.的季度营收约是ABVC BIOPHARMA, INC.的1.3倍（$1.0M vs $796.0K），ABVC BIOPHARMA, INC.净利率更高（-256.6% vs -544.1%，领先287.5%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs -38.5%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs -25.0%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
CXApp Inc.是一家专注于数字工作场所体验解决方案的科技企业，提供员工参与度提升、办公空间优化、访客管理、混合办公协调等云服务产品，主要服务北美、亚太、欧洲的中大型企业客户。
ABVC vs CXAI — 直观对比
营收规模更大
CXAI
是对方的1.3倍
$796.0K
营收增速更快
ABVC
高出142.9%
-38.5%
净利率更高
ABVC
高出287.5%
-544.1%
两年增速更快
ABVC
近两年复合增速
-25.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $1.0M |
| 净利润 | $-2.0M | $-5.6M |
| 毛利率 | 100.0% | 86.9% |
| 营业利润率 | -246.8% | -576.9% |
| 净利率 | -256.6% | -544.1% |
| 营收同比 | 104.5% | -38.5% |
| 净利润同比 | -417.4% | -56.7% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCCXAI
| Q4 25 | — | $1.0M | ||
| Q3 25 | $796.0K | $1.1M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | $2.0K | $1.7M | ||
| Q3 24 | $389.3K | $1.9M | ||
| Q2 24 | $117.1K | $1.8M | ||
| Q1 24 | $1.2K | $1.8M |
净利润ABVCCXAI
| Q4 25 | — | $-5.6M | ||
| Q3 25 | $-2.0M | $-3.2M | ||
| Q2 25 | — | $-3.1M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-3.5M | ||
| Q3 24 | $-394.8K | $-5.4M | ||
| Q2 24 | $-942.3K | $-5.3M | ||
| Q1 24 | $-2.8M | $-5.2M |
毛利率ABVCCXAI
| Q4 25 | — | 86.9% | ||
| Q3 25 | 100.0% | 89.0% | ||
| Q2 25 | — | 86.0% | ||
| Q1 25 | — | 87.7% | ||
| Q4 24 | 100.0% | 86.0% | ||
| Q3 24 | 99.9% | 80.4% | ||
| Q2 24 | 99.8% | 80.0% | ||
| Q1 24 | 77.0% | 82.0% |
营业利润率ABVCCXAI
| Q4 25 | — | -576.9% | ||
| Q3 25 | -246.8% | -343.4% | ||
| Q2 25 | — | -336.1% | ||
| Q1 25 | — | -306.0% | ||
| Q4 24 | — | -169.7% | ||
| Q3 24 | -77.7% | -194.3% | ||
| Q2 24 | -734.2% | -206.7% | ||
| Q1 24 | -235539.8% | -197.3% |
净利率ABVCCXAI
| Q4 25 | — | -544.1% | ||
| Q3 25 | -256.6% | -283.4% | ||
| Q2 25 | — | -256.7% | ||
| Q1 25 | — | -132.0% | ||
| Q4 24 | — | -213.6% | ||
| Q3 24 | -101.4% | -286.5% | ||
| Q2 24 | -804.4% | -297.6% | ||
| Q1 24 | -235203.2% | -284.4% |
每股收益（稀释后）ABVCCXAI
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $-0.08 | — | ||
| Q1 24 | $-0.29 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $11.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $14.0M |
| 总资产 | $21.2M | $32.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABVCCXAI
| Q4 25 | — | $11.1M | ||
| Q3 25 | $257.2K | $5.1M | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | $313.1K | $4.9M | ||
| Q3 24 | $208.2K | — | ||
| Q2 24 | $200.0K | — | ||
| Q1 24 | $106.4K | — |
股东权益ABVCCXAI
| Q4 25 | — | $14.0M | ||
| Q3 25 | $12.1M | $15.2M | ||
| Q2 25 | — | $14.3M | ||
| Q1 25 | — | $15.6M | ||
| Q4 24 | $1.2M | $15.6M | ||
| Q3 24 | $1.6M | $13.6M | ||
| Q2 24 | $1.8M | $16.3M | ||
| Q1 24 | $1.7M | $20.9M |
总资产ABVCCXAI
| Q4 25 | — | $32.4M | ||
| Q3 25 | $21.2M | $28.5M | ||
| Q2 25 | — | $29.6M | ||
| Q1 25 | — | $29.3M | ||
| Q4 24 | $7.5M | $31.8M | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $8.0M | — | ||
| Q1 24 | $8.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $-3.6M |
| 自由现金流经营现金流 - 资本支出 | — | $-3.6M |
| 自由现金流率自由现金流/营收 | — | -355.5% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-10.4M |
8季度趋势，按日历期对齐
经营现金流ABVCCXAI
| Q4 25 | — | $-3.6M | ||
| Q3 25 | $-964.7K | $-2.8M | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | $-979.0K | ||
| Q4 24 | $-1.8M | $-2.7M | ||
| Q3 24 | $60.2K | $-2.1M | ||
| Q2 24 | $-211.4K | $-1.9M | ||
| Q1 24 | $-955.8K | $-650.0K |
自由现金流ABVCCXAI
| Q4 25 | — | $-3.6M | ||
| Q3 25 | — | $-2.8M | ||
| Q2 25 | — | $-3.0M | ||
| Q1 25 | — | $-984.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-2.1M | ||
| Q2 24 | — | $-1.9M | ||
| Q1 24 | — | $-668.0K |
自由现金流率ABVCCXAI
| Q4 25 | — | -355.5% | ||
| Q3 25 | — | -248.1% | ||
| Q2 25 | — | -247.2% | ||
| Q1 25 | — | -80.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -109.3% | ||
| Q2 24 | — | -108.6% | ||
| Q1 24 | — | -36.7% |
资本支出强度ABVCCXAI
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 1.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
